Complement-targeted therapies in kidney transplantation—insights from preclinical studies
Open Access
- 13 October 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 984090
Abstract
Aberrant activation of the complement system contributes to solid-organ graft dysfunction and failure. In kidney transplantation, the complement system is implicated in the pathogenesis of antibody- and cell-mediated rejection, ischemia-reperfusion injury, and vascular injury. This has led to the evaluation of select complement inhibitors (e.g., C1 and C5 inhibitors) in clinical trials with mixed results. However, the complement system is highly complex: it is composed of more than 50 fluid-phase and surface-bound elements, including several complement-activated receptors—all potential therapeutic targets in kidney transplantation. Generation of targeted pharmaceuticals and use of gene editing tools have led to an improved understanding of the intricacies of the complement system in allo- and xeno-transplantation. This review summarizes our current knowledge of the role of the complement system as it relates to rejection in kidney transplantation, specifically reviewing evidence gained from pre-clinical models (rodent and nonhuman primate) that may potentially be translated to clinical trials.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (U19AI131471, Opportunities Pool Round 16, T32 AI141342-03)
This publication has 123 references indexed in Scilit:
- Properdin and Factor H: Opposing Players on the Alternative Complement Pathway “See-Saw”Frontiers in Immunology, 2013
- Human CD55 Expression Blocks Hyperacute Rejection and Restricts Complement Activation in Gal Knockout Cardiac XenograftsTransplantation, 2012
- Anti-Complement Component C5 mAb Synergizes with CTLA4Ig to Inhibit Alloreactive T cells and Prolong Cardiac Allograft Survival in MiceAmerican Journal of Transplantation, 2011
- Deficiency of C5aR Prolongs Renal Allograft SurvivalJournal of the American Society of Nephrology, 2010
- Complement 5a Receptor Inhibition Improves Renal Allograft SurvivalJournal of the American Society of Nephrology, 2008
- Biological activities of C1 inhibitorMolecular Immunology, 2008
- Locally produced C5a binds to T cell–expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosisBlood, 2008
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T CellsImmunity, 2008
- The Role of Complement in Inflammatory Diseases From Behind the Scenes into the SpotlightThe American Journal of Pathology, 2007
- Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathwayImmunobiology, 2007